Crohn's disease, infliximab and idiopathic thrombocytopenic purpura [1]

Inflammatory Bowel Diseases

Volumn 10, Issue 5, 2004, Pages 698-700

  Selby, Lisbeth A ^a   Hess, David ^a   Shashidar, Harohalli ^a   de Villiers, Willem J S ^a  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID DERIVATIVE; DICYCLOVERINE; IMMUNOGLOBULIN; INFLIXIMAB; MEGESTROL; MERCAPTOPURINE; MESALAZINE; METHYLPREDNISOLONE; METRONIDAZOLE; OMEPRAZOLE; PLACEBO; PREDNISONE; SALAZOSULFAPYRIDINE; SERTRALINE; TUMOR NECROSIS FACTOR ALPHA;

ABDOMINAL PAIN; ADOLESCENT; BONE MARROW BIOPSY; CASE REPORT; CLINICAL FEATURE; CLINICAL TRIAL; COLITIS; COLON BIOPSY; COLON RESECTION; COLONOSCOPY; CROHN DISEASE; DISEASE ASSOCIATION; ERYTHROCYTE TRANSFUSION; HEMATOCHEZIA; HEPATOMEGALY; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; INTESTINE ULCER; LABORATORY TEST; LETTER; LYMPHADENOPATHY; MALE; NAUSEA; PATIENT REFERRAL; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RECTUM ULCER; RHEUMATOID ARTHRITIS; SIGMOIDOSCOPY; SPLENOMEGALY; THROMBOCYTOPENIA;

ADOLESCENT; ANTIBODIES, MONOCLONAL; CROHN DISEASE; GASTROINTESTINAL AGENTS; HUMANS; MALE; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 4644308767     PISSN: 10780998     EISSN: None     Source Type: Journal    
DOI: 10.1097/00054725-200409000-00033     Document Type: Letter

References (13)

1. Cines DB, Blanchette VS. Immune thrombocytopenic purpura. N Engl J Med. 2002; 346: 995-1008.
2. McMillan R. Autoantibodies and autoantigens in chronic immune thrombocytopenic purpura. Semin Hematol. 2000;37:239-248.
3. Carcao MD, Zipursky A, Butchart S, et al. Short-course oral prednisone therapy in children presenting with acute immune thrombocyotpenic purpura (ITP). Acta Paediatr. 1998; 87: 71-74.
4. Kühne T, Elinder G, Blanchette VS, et al. Current management issues of childhood and adult immune thrombocytopenic purpura (ITP). Acta Paediatr. 1998;87:75-81.
5. Zlatanic J, Korelitz B, Wisch N, et al. Inflammatory bowel disease and immune thrombocytopenic purpura: is there a correlation? Am J Gastroenterol. 1997;92:2285-2288.
6. Remicade® package insert
7. George JN, Woolf SH, Raskob GE, et al. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood. 1996;88:3-40.
8. Lamers CB, Griffioen G, van Hogezand RA, et al. Azathioprine: An update on clinical efficacy and safety in IBD. Scand J Gastroenterol Supp. 1999;230:111-115.
9. Lee RG, et al, eds. Wintrobe's Clinical Hematology, 10th ed. Baltimore: Williams and Wilkins, 1999.
10. Lülgering A, Schmidt M, Lügering, N, et al. Infliximab induces apoptosis in monocytes from patients with chronic active Crohn's disease by using a caspase-dependent pathway. Gustroenterology. 2001; 121: 1145-1157.
11. Ten Hove, van Montfrans C, Peppelenbosch MP, et al. Infliximab treatment induces apoptosis of lamina propria T lymphocytes in Crohn's disease. Gut 2002; 50: 206-211.
12. Webber NP, Mascarenhas JO, Crow MK, et al. Functional properties of lymphocytes in idiopathic thrombocytopenic purpura. Hum Immunol. 2001; 62: 1346-1355.
13. Hed J. Role of complement in immune or idiopathic thrombocytopenic purpura. Acta Paediatr. 1998; 87: 37-40.